SkinBioTherapeutics (LSE:SBTX) ROE % Adjusted to Book Value : -11.78% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is SkinBioTherapeutics ROE % Adjusted to Book Value?

SkinBioTherapeutics's ROE % for the quarter that ended in Dec. 2023 was -94.58%. SkinBioTherapeutics's PB Ratio for the quarter that ended in Dec. 2023 was 8.03. SkinBioTherapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -11.78%.

SkinBioTherapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for SkinBioTherapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SkinBioTherapeutics ROE % Adjusted to Book Value Chart

SkinBioTherapeutics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-4.76

-5.32

-1.94

-5.74

-12.17

SkinBioTherapeutics Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial										-2.95	-8.18	-7.19	-18.55	-11.78

Competitive Comparison of SkinBioTherapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, SkinBioTherapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SkinBioTherapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SkinBioTherapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where SkinBioTherapeutics's ROE % Adjusted to Book Value falls into.

SkinBioTherapeutics ROE % Adjusted to Book Value Calculation

SkinBioTherapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-126.85%	/	10.42
	=	-12.17%

SkinBioTherapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-94.58%	/	8.03
	=	-11.78%

SkinBioTherapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of SkinBioTherapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

SkinBioTherapeutics (LSE:SBTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SkinBioTherapeutics PLC (LSE:SBTX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF

Website

https://www.skinbiotherapeutics.com

SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.